![Pamela Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Klein
Directeur/Membre du Conseil chez
ARGENX SE
Fortune : 2 M $ au 31/05/2026
Profil
Pamela M.
Klein is the founder of Pmk Bioresearch, serving as President since 2008.
Current jobs include Independent Non-Executive Director at argenx SE since 2016, Independent Director & Board of Directors at Ona Therapeutics SL, Independent Director; Board of Directors at Frontier Medicines Corp.
since 2023, Independent Director; Board of Directors at Sardona Therapeutics, Inc. since 2023, Venture Partner at Ysios Capital Partners SGEIC SA since 2020, and Advisor at Proxenia Venture Partners LLC.
Former jobs include Chairman at I-Mab in 2024, Non-Executive Director at Patrys Ltd. from 2019 to 2025, Research Director-NCI Navy Breast Center at National Cancer Institute from 1995 to 2001, Independent Director at F-Star Therapeutics, Inc. from 2019 to 2020, Director at F-Star Therapeutics, Inc., Board of Directors at F-Star Therapeutics, Inc. from 2019 to 2020, Independent Director at F-star Therapeutics, Inc. from 2020 to 2023, Independent Director at Jiya Acquisition Corp., Vice President-Development at Genentech, Inc. from 2001 to 2007, Chief Medical Officer at Syndax Pharmaceuticals, Inc., Chief Medical Officer at Intellikine LLC from 2008 to 2011, and Chief Medical Officer at Olema Pharmaceuticals, Inc. from 2018 to 2022.
Education includes a doctorate from Stritch School of Medicine conferred in 1992 and a doctorate from The California State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARGENX SE 0 % | 19/02/2026 | 2 290 ( 0 % ) | 2 M $ | 31/05/2026 |
Postes actifs de Pamela Klein
| Sociétés | Poste | Début |
|---|---|---|
| ARGENX SE | Directeur/Membre du Conseil | 28/04/2016 |
Proxenia Venture Partners LLC
 Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Consultant / Advisor | - |
Sardona Therapeutics, Inc.
 Sardona Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer therapy services | Directeur/Membre du Conseil | 01/01/2023 |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Directeur/Membre du Conseil | - |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Directeur/Membre du Conseil | 01/01/2023 |
Pmk Bioresearch | Fondateur | 01/01/2008 |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 01/06/2020 |
Anciens postes connus de Pamela Klein
| Sociétés | Poste | Fin |
|---|---|---|
| PATRYS LIMITED | Directeur/Membre du Conseil | 17/06/2025 |
| NOVABRIDGE BIOSCIENCES | Président | 15/07/2024 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Pamela Klein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Stritch School of Medicine
 Stritch School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Ona Therapeutics SL
Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets drugs for treatment and cancers and other diseases | Health Technology |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Develops medicines that redefine the course of debilitating diseases | Health Technology |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Finance |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
Sardona Therapeutics, Inc.
Sardona Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides cancer therapy services | Health Services |
Pmk Bioresearch |
